Thermosensitive Nanostructure for Hyperthermia Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current magnetic hyperthermia treatments using superparamagnetic iron oxide nanoparticles lack a mechanism for concurrent drug delivery and enhanced MRI contrast, as they do not efficiently release drugs at the tumor site and provide limited contrast enhancement.
Innovation Solution
A thermosensitive polymer nanostructure with a lower critical solution temperature of 40-45°C, encapsulating magnetic nanoparticles and optionally a drug or NO donor, which collapses and releases the drug when heated, enhancing drug delivery and MRI contrast by increasing the r2 value and specific absorption rate of the nanoparticles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If superparamagnetic iron oxide nanoparticles are used for magnetic hyperthermia treatment, then heat generation at the tumor site is improved, but drug delivery capability and MRI contrast enhancement are insufficient
Solution Approach 1:
The patent combines magnetic nanoparticles, thermosensitive polymer, and drug into a single integrated nanostructure. The magnetic nanoparticles provide heat generation, the thermosensitive polymer provides temperature-responsive drug release, and the combination achieves both hyperthermia treatment and targeted drug delivery simultaneously, resolving the contradiction between heat generation and drug delivery capability
Solution Approach 2:
The thermosensitive polymer nanostructure serves multiple functions: it acts as a drug carrier, a temperature sensor, and a release mechanism. The same structure that generates heat through magnetic nanoparticles also controls drug release based on temperature changes, providing universal functionality that addresses both hyperthermia and drug delivery requirements
2Temperature
If superparamagnetic iron oxide nanoparticles are used for magnetic hyperthermia treatment, then heat generation at the tumor site is improved, but MRI contrast enhancement is limited
Solution Approach 1:
The patent creates a composite material system where magnetic nanoparticles are embedded within a thermosensitive polymer matrix. This composite structure enhances MRI contrast by combining the magnetic properties of the nanoparticles with the polymer matrix, achieving superior contrast enhancement (up to 5 times that of commercial developers) while maintaining effective heat generation capability
3Device complexity
If conventional nanoparticles are used without thermosensitive polymer, then structural simplicity is maintained, but controlled drug release at target site is not achieved
Solution Approach 1:
The patent utilizes the thermosensitive polymer's ability to change its physical properties (solubility, conformation) in response to temperature changes. Below the lower critical solution temperature (LCST), the polymer is soluble and maintains a relaxed state, allowing drug encapsulation. Above the LCST, the polymer becomes insoluble and collapses, triggering controlled drug release. This parameter change mechanism enables controlled drug release without significantly complicating the overall nanostructure
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The thermosensitive nanostructure effectively releases drugs at the tumor site during hyperthermia, increasing the specific absorption rate of magnetic nanoparticles by 1.5 times that of commercial developers and enhancing MRI contrast by up to 5 times, facilitating targeted and concurrent drug treatment.
Implementation Method 1
In magnetic hyperthermia treatment, magnetic particles are subjected to an applied alternating magnetic field to generate heat at the tumor site
Implementation Method 2
a thermosensitive polymer nanostructure having a lower critical solution temperature (LCST) of about 40-45° C.
Implementation Method 3
the thermosensitive polymer nanostructure of the invention may increase the r2 value of the encapsulated magnetic nanoparticles, resulting in greater contrast enhancement on MRI
Data Source
AI summary
A thermosensitive nanostructure for hyperthermia treatment. Magnetic nanoparticles are encapsulated in a thermosensitive polymer nanostructure having a lower critical solution temperature (LCST) of about 40-45° C. The thermosensitive polymer nanostructure may carry a drug. When the magnetic nanoparticles are heated to 40-45° C. by application of an alternating magnetic field in hyperthermia treatment, the thermosensitive polymer nanostructure collapses to release the drug, thus providing concurrent drug treatment.